Drug
Vinorelbine clinical trials
Also written KW-2307.
Includes 1 study of Liposomal Vinorelbine Tartrate.
- studies test it
- 238
- open now
- 12
- in phase 3
- 41
- first study started
- 1994
Keep track of what changes. Save the Vinorelbine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
237 studies that test it; most in 2008 (17)
| Year | Studies |
|---|---|
| 1994 | 1 |
| 1996 | 1 |
| 1997 | 4 |
| 1998 | 6 |
| 1999 | 9 |
| 2000 | 7 |
| 2001 | 14 |
| 2002 | 12 |
| 2003 | 13 |
| 2004 | 12 |
| 2005 | 9 |
| 2006 | 7 |
| 2007 | 13 |
| 2008 | 17 |
| 2009 | 9 |
| 2010 | 10 |
| 2011 | 10 |
| 2012 | 8 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 16 |
| 2017 | 8 |
| 2018 | 5 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 3 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 45
- Phase 2
- 161
- Phase 3
- 41
- Phase 4
- 3
- No phase
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 37 · Other 201
Hellenic Oncology Research Group (9) · Fudan University (8) · Alliance for Clinical Trials in Oncology (6) · Children's Oncology Group (6) · University of Washington (6) · SWOG Cancer Research Network (6) · Dana-Farber Cancer Institute (6) · Memorial Sloan Kettering Cancer Center (5)
Often tested with
Tested in the same studies.
Gemcitabine (47) · Cisplatin (31) · Docetaxel (29) · Capecitabine (28) · Trastuzumab (26) · Paclitaxel (23) · Carboplatin (20) · Cyclophosphamide (14)
Studies
Open first, then newest update. How each study uses Vinorelbine is read from its arms, and is right about nine times in ten.
Testing it · 238
- Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast CancerRecruitingPhase 2Henan Cancer HospitalNCT05296577Written as anlotinib and vinorelbine
- A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With CancerRecruitingPhase 2Eli Lilly and CompanyNCT05999994Written as Vinorelbine
- European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory TumorsRecruitingPhase 1/2Gustave Roussy, Cancer Campus, Grand ParisNCT02813135Written as Vinorelbine
- A Study of BV-AVD in People With Bulky Hodgkin LymphomaRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT06377566Written as Vinorelbine
- LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic PatientsRecruitingNot applicableUniversity of Illinois at ChicagoNCT06576635Written as Vinorelbine
- Anlotinib Hydrochloride Capsules in Maintenance Treatment for Intermediate-High Risk Rhabdomyosarcoma in ChildrenNot yet recruitingPhase 2Sun Yat-sen UniversityNCT07137884Written as Anlotinib+Cyclophosphamide+Vinorelbine
- Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.Not yet recruitingNot applicableQIAO LINCT06857747Written as Vinorelbine
- Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGSNot yet recruitingPhase 2Peking University Shenzhen HospitalNCT06692491Written as Vinorelbine
- FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcomaRecruitingPhase 1/2University of BirminghamNCT04625907Written as Vinorelbine
- Inetetamab Combined With Pyrotinib Plus Oral Vinorelbine for the Treatment of HER2-positive Metastatic Breast CancerRecruitingPhase 2The First Affiliated Hospital with Nanjing Medical UniversityNCT05823623Written as Oral Vinorelbine Tartrate
- Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer PatientsRecruitingPhase 2European Institute of OncologyNCT04304352Written as Vinorelbine
- Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D)Not yet recruitingPhase 2Fudan UniversityNCT04922008Written as vinorelbine and trastuzumab
- Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung CancerActive, not recruitingPhase 3Alliance for Clinical Trials in OncologyNCT06632327Written as Vinorelbine
- A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk RhabdomyosarcomaActive, not recruitingPhase 3Children's Oncology GroupNCT04994132Written as Vinorelbine Tartrate
- A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer(PANKU-Breast01)Active, not recruitingPhase 3Sichuan Baili Pharmaceutical Co., Ltd.NCT06343948Written as Vinorelbine
- A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer(PANKU-Breast02)Active, not recruitingPhase 3Sichuan Baili Pharmaceutical Co., Ltd.NCT06382142Written as Vinorelbine
- Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent RhabdomyosarcomaActive, not recruitingPhase 1Jonsson Comprehensive Cancer CenterNCT04299113Written as Vinorelbine
- Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung CancerActive, not recruitingPhase 2Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityNCT04922658Written as Surufatinib Plus Vinorelbine
- Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung CancerCompletedPhase 2University Hospital, BrestNCT03801304Written as Vinorelbine
- Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID)CompletedPhase 2Fudan UniversityNCT04296162Written as Vinorelbine
See all 238 studies that test Vinorelbine →
Given in every arm · 66 — Vinorelbine is usual care beside what is tested
- Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin LymphomaRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT03618550Written as vinorelbine
- ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin LymphomaRecruitingPhase 2Michael Spinner, MDNCT07021989Written as Vinorelbine
- ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast CancerRecruitingPhase 2ALX Oncology Inc.NCT07007559Written as Vinorelbine
- A Phase II Study of HLX22 in Combination With Trastuzumab and Chemotherapy in HER2-Positive Locally Advanced or Metastatic Breast Cancer PatientsNot yet recruitingPhase 2Shanghai Henlius BiotechNCT07824869Written as Vinorelbine
- A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)RecruitingPhase 3Children's Oncology GroupNCT07466316Written as Vinorelbine Tartrate
- Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk DiseaseRecruitingPhase 2St. Jude Children's Research HospitalNCT06023641Written as Vinorelbine
- A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast CancerRecruitingPhase 3Jazz PharmaceuticalsNCT06435429Written as Vinorelbine
- A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.RecruitingPhase 3Qilu Pharmaceutical Co., Ltd.NCT05487391Written as Vinorelbine Tartrate
- Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCLRecruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT06489808Written as Vinorelbine
- Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast CancerRecruitingPhase 2Fudan UniversityNCT06355037Written as Taxane/Anthracycline/Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin/UTD1/platinum
- A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast CancerRecruitingPhase 1/2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06202261Written as Vinorelbine tartrate injection
- Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast CancerNot yet recruitingPhase 2Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT06229067Written as Vinorelbine
- Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk RhabdomyosarcomaActive, not recruitingPhase 3National Cancer Institute (NCI)NCT02567435Written as Vinorelbine
- Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]CompletedPhase 3Hoffmann-La RocheNCT02486718Written as Vinorelbine
- CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell TumorCompletedPhase 1/2Eli Lilly and CompanyNCT04145349Written as Vinorelbine
- The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast CancerActive, not recruitingPhase 2Adrienne G. WaksNCT03414658Written as Vinorelbine
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryCompletedPhase 3National Cancer Institute (NCI)NCT00324805Written as Vinorelbine Tartrate
- A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast CancerCompletedPhase 3Japan Breast Cancer Research GroupNCT02514681Written as Vinorelbine
- Inosine Reverse Chemo Resistance in Triple Negative Breast CancerCompletedPhase 2Fudan UniversityNCT06355024Written as Taxane/Anthracycline/Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin/UTD1/platinum
- Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing CancersCompletedPhase 1Jazz PharmaceuticalsNCT02892123Written as Vinorelbine
Showing 20 of 66.
As the comparator · 55 — what is tested is compared with Vinorelbine
- A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2RecruitingPhase 3RemeGen Co., Ltd.NCT04400695Written as Vinorelbine Tartrate Injection
- A Phase 3 Trial in Advanced Epithelioid MesotheliomaNot yet recruitingPhase 3Vivace Therapeutics, IncNCT07824986Written as Vinorelbine
- Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung DiseaseNot yet recruitingPhase 2Intergroupe Francophone de Cancerologie ThoraciqueNCT07420439Written as Vinorelbine
- YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast CancerRecruitingPhase 3MediLink Therapeutics (Suzhou) Co., Ltd.NCT07461454Written as Vinorelbine
- Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast CancerRecruitingPhase 3Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.NCT06081959Written as Vinorelbine
- A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of CareRecruitingPhase 3Jiangsu Alphamab Biopharmaceuticals Co., LtdNCT07533123Written as Vinorelbine Tartrate Injection
- Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung CancerRecruitingPhase 2Gustave Roussy, Cancer Campus, Grand ParisNCT07001618Written as Vinorelbine i.v. 25 mg/m²
- A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLCRecruitingPhase 3Maia BiotechnologyNCT06908304Written as Vinorelbine
- Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously TreatedRecruitingPhase 3Intergroupe Francophone de Cancerologie ThoraciqueNCT06908993Written as Vinorelbine
- JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer SubjectsRecruitingPhase 3Jiangsu Alphamab Biopharmaceuticals Co., LtdNCT06079983Written as Vinorelbine tartrate injection
- Organoid-based Functional Precision Therapy for Advanced Breast CancerRecruitingPhase 2Guangdong Provincial People's HospitalNCT06102824Written as Vinorelbine
- Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast CancerRecruitingPhase 3Sun Yat-sen UniversityNCT06268652Written as Vinorelbine
- DP303c in Patients With HER2-positive Advanced Breast CancerNot yet recruitingPhase 3CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05901935Written as Vinorelbine Tartrate
- Clinical Trial of Neoadjuvant Targeted Treatment to NSCLC PatientsNot yet recruitingPhase 3Sun Yat-sen UniversityNCT03203590Written as Oral Navelbine + Carboplatin
- Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in PIK3CA-mutated HER2+ Advanced BC (ALPHABET)TerminatedPhase 3Spanish Breast Cancer Research GroupNCT05063786Written as Vinorelbine
- A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung CancerActive, not recruitingPhase 3Hoffmann-La RocheNCT03456076Written as Vinorelbine
- A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological FeaturesActive, not recruitingPhase 3AstraZenecaNCT06564844Written as Vinorelbine
- A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)Active, not recruitingPhase 3Merck Sharp & Dohme LLCNCT06459180Written as Vinorelbine
- A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)Active, not recruitingPhase 3AstraZenecaNCT05104866Written as Vinorelbine
- PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural MesotheliomaCompletedPhase 3ETOP IBCSG Partners FoundationNCT02991482Written as Vinorelbine
Showing 20 of 55.
Codes
What other systems call Vinorelbine · ClinicalTrials.gg INT006672
- MeSH (NLM) D000077235VinorelbineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) Q6C979R91YVINORELBINEConfirmed FDA, NLM, Wikidata
- RxNorm 39541Confirmed FDA, Wikidata
- Wikidata Q420532vinorelbineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1275VinorelbineOne source FDA
- DrugBank DB00361One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077235 | Vinorelbine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | Q6C979R91Y | VINORELBINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 39541 | — | Confirmed FDA, Wikidata |
| Wikidata | Q420532 | vinorelbine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1275 | Vinorelbine | One source FDA |
| DrugBank | DB00361 | — | One source Wikidata |
Also registered as vinorelbine tartrate (UNII 253GQW851Q · RxNorm 114527).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.